Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Atlas Antibodies 2023 AB
AB
Active
Org 5594207135
Economic activity was not specified by tax authority
· NACE 0000
Est. 2023
0 employees
Watchlist
Share
Sweden
/
Companies
/
Economic activity was not specified by tax authority
/
Atlas Antibodies 2023 AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AM
Alexandros Martin Kouvatsos
Chief Auditor
Chief Auditor
2023
Former (1)
EC
Eva Camilla Nilsson
Chief Auditor
Chief Auditor
2023 – 2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
ML
Madeleine Louise Agneta Kores
Board of Directors
2023
MB
Malte Björn S:t Cyr Ohm
Deputy Board Member
2023
BE
Britt Eva Maria Faervik
Board of Directors
2024
IF
Ingela Fredrika Hofverberg
Chairman
2024
Former (18)
JA
Jan Anders Fredrik Lovén
Deputy Board Member
2023 – 2023
JT
Jan Totte Dahlin
Deputy Board Member
2023 – 2023
VE
Viktor Elias Bergman Gullmark
Deputy Board Member
2023 – 2023
AH
Andreas Hans Eddie Ottosson
Deputy Board Member
2023 – 2023
AM
Anna Matilda Sjödin
Deputy Board Member
2023 – 2023
AC
Anna Camilla Biström
Deputy Board Member
2023 – 2023
LA
Lars Anders Larsson
Board of Directors
2023 – 2023
LM
Linn Mikaela Engman
Deputy Board Member
2023 – 2023
ES
Emelie Sofia Bergh
Deputy Board Member
2023 – 2023
AC
Anna Carolina Maria Bjarnhagen
Deputy Board Member
2023 – 2023
EA
Elin Anna Margareta Spjut
Deputy Board Member
2023 – 2023
EE
Eva Evelina Evelyn Sjöstedt
Deputy Board Member
2023 – 2023
MS
Mari Sinikka Kovaniemi Feldt
Deputy Board Member
2023 – 2023
OK
Olina Kristina Maria Wåhlstedt
Deputy Board Member
2023 – 2023
JE
Julia Engla Eva M Arnfridsdotter
Deputy Board Member
2023 – 2023
EM
Erik Martin Skoglund
Board of Directors
2023 – 2023
PU
Peter Ulvskjold
Chairman
2023 – 2024
AK
Anna Klara Alina Bruksås Nybjörk
Deputy Board Member
2023 – 2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Atlas Antibodies 2023 AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot